Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01843504 · ClinicalTrials.gov registry record · Phase 2
Platelet-Rich Plasma (PRP) Injection for the Treatment of Chronic Patellar Tendinopathy
A Phase 2 study, sponsored by University of Wisconsin, Madison.
- Completed
- Registry status
- Phase 2
- Development phase
- 29
- Enrollment target
NCT01843504 is a Phase 2 study that has completed, run by University of Wisconsin, Madison. The registered enrollment target is 29 participants.
The verdict
NCT01843504, a Phase 2 study, has completed, sponsored by University of Wisconsin, Madison.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 29 participants
- Enrollment target
Study Summary
The goal of this study is to find an effective treatment for chronic patellar tendinopathy (PT). Investigators will conduct a 32-week randomized controlled clinical trial to determine whether platelet rich plasma (PRP) injections improve disease-specific clinical outcomes with correlation to a new method of ultrasound (US) imaging assessment called Acoustoelastography (AE). Positive findings of PRP compared to control would suggest future larger scale studies to help establish an optimal protocol for the nonsurgical management of PT.
Interventions
- OTHER saline
- BIOLOGICAL platelet rich plasma
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 29 participants |
| Start Date | 2014-01 |
| Est. Completion | 2024-02-29 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01843504
The ClinicalTrials.gov registry entry for NCT01843504 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 29 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Wisconsin, Madison, which has 1,039 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which saline is the first listed.
NCT01843504 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01843504 about?
NCT01843504 is a clinical study titled "Platelet-Rich Plasma (PRP) Injection for the Treatment of Chronic Patellar Tendinopathy". The goal of this study is to find an effective treatment for chronic patellar tendinopathy (PT). Investigators will conduct a 32-week randomized controlled clinical trial to determine whether platelet rich plasma (PRP) injections improve disease-specific clinical outcomes with correlation to a new m...
What is the current status of trial NCT01843504?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 29 participants. The study started on 2014-01. Estimated completion is 2024-02-29.
What interventions are being tested in trial NCT01843504?
The interventions under investigation include: saline (OTHER), platelet rich plasma (BIOLOGICAL).
Who is sponsoring clinical trial NCT01843504?
This trial is sponsored by University of Wisconsin, Madison, which has 1,039 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.